Stay updated on Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page.

Latest updates to the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page
- Check7 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a minor update to the page version. This change does not modify visible content or user workflow.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe software/UI version indicator on the page updates from Revision v3.5.0 to Revision v3.5.3, reflecting a site release rather than a change to the clinical trial details.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded the term Squamous cell carcinoma of the head and neck and included a link to Genetic and Rare Diseases Information Center under resources.SummaryDifference0.2%

- Check64 days agoChange DetectedSite version updated from v3.4.3 to v3.5.0. No user-facing changes to the study details page were detected.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; the content and function of the study page remain unchanged.SummaryDifference0.1%

- Check100 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2; no clinical content or study details were modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page.